Research Partners

xINFORM is xCures’ first solution where we work directly with patients and use artificial intelligence to review the latest treatments doctors have been using and find the best treatment options for patients. Enroll today and be one of the first to get access to the power of xINFORM.

xCures is collaborating with CancerCompass to allow consumers who contact CancerCompass to get immediate help as well as premium access to the xCures platform and services.

Cancer Commons is a nonprofit that provides hope to advanced cancer patients by offering a highly customized and personal experience and helping them quickly identify and access their best possible treatment.

xCures partnered with BioMed Valley Discoveries to offer expanded access to ulixertinib, a first-in-class ERK1/2 inhibitor, for patients with advanced solid tumors who are no longer responding to or have exhausted standard of care. Detailed inclusion/exclusion criteria can be found at clinicaltrials.gov.